Jacobson TA - Search Results

1

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

Wei MY, Ito MK, Cohen JD, Brinton EA, Jacobson TA. Wei MY, et al. Among authors: jacobson ta. J Clin Lipidol. 2013 Sep-Oct;7(5):472-83. doi: 10.1016/j.jacl.2013.03.001. Epub 2013 Mar 13. J Clin Lipidol. 2013. PMID: 24079289

2

Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease.

Jacobson TA. Jacobson TA. Curr Opin Lipidol. 1997 Dec;8(6):369-74. doi: 10.1097/00041433-199712000-00008. Curr Opin Lipidol. 1997. PMID: 9412778 Review.

3

Fibrates in combination with statins in the management of dyslipidemia.

Jacobson TA, Zimmerman FH. Jacobson TA, et al. J Clin Hypertens (Greenwich). 2006 Jan;8(1):35-41; quiz 42-3. doi: 10.1111/j.1524-6175.2005.05278.x. J Clin Hypertens (Greenwich). 2006. PMID: 16407687 Free PMC article. Review.

4

Missed opportunity in the treatment of hyperlipidemia in patients with coronary heart disease: the primary care setting.

Hoskins MH, Jacobson TA. Hoskins MH, et al. Among authors: jacobson ta. J Natl Med Assoc. 2006 Jan;98(1):58-62. J Natl Med Assoc. 2006. PMID: 16532979 Free PMC article.

5

Statin safety: lessons from new drug applications for marketed statins.

Jacobson TA. Jacobson TA. Am J Cardiol. 2006 Apr 17;97(8A):44C-51C. doi: 10.1016/j.amjcard.2005.12.009. Epub 2006 Feb 2. Am J Cardiol. 2006. PMID: 16581328

6

Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly.

Jacobson TA. Jacobson TA. Drug Saf. 2006;29(5):421-48. doi: 10.2165/00002018-200629050-00005. Drug Saf. 2006. PMID: 16689557 Review.

7

Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.

Jacobson TA, Gutkin SW, Harper CR. Jacobson TA, et al. Curr Med Res Opin. 2006 Jun;22(6):1065-73. doi: 10.1185/030079906X104605. Curr Med Res Opin. 2006. PMID: 16846539 Clinical Trial.

8

The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?

Jacobson TA. Jacobson TA. Mayo Clin Proc. 2006 Sep;81(9):1225-31. doi: 10.4065/81.9.1225. Mayo Clin Proc. 2006. PMID: 16970219 Review.

9

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA. Harper CR, et al. Among authors: jacobson ta. Curr Opin Lipidol. 2007 Aug;18(4):401-8. doi: 10.1097/MOL.0b013e32825a6773. Curr Opin Lipidol. 2007. PMID: 17620856 Review.

10

Initiating statins in the elderly: the evolving challenge.

Walker DB, Jacobson TA. Walker DB, et al. Among authors: jacobson ta. Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):182-7. doi: 10.1097/MED.0b013e3282f7cd6d. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18316955 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters